Serum cytokeratin-18 fragments as quantitative markers of epithelial apoptosis in liver and intestinal graft-versus-host disease.
about
Toward unraveling the complexity of simple epithelial keratins in human diseaseNew Prognostic Biomarkers in Patients With Traumatic Brain InjuryCytokeratins in gastroenterology. Systematic reviewGraft-versus-host disease biomarkers: omics and personalized medicineGene markers of cellular aging in human multipotent stromal cells in culture.Complementary Role of Fibroblast Growth Factor 21 and Cytokeratin 18 in Monitoring the Different Stages of Nonalcoholic Fatty Liver Disease.Serum levels of caspase-cleaved cytokeratin-18 and mortality are associated in severe septic patients: pilot studySerum markers of hepatocyte death and apoptosis are non invasive biomarkers of severe fibrosis in patients with alcoholic liver disease.Various forms of tissue damage and danger signals following hematopoietic stem-cell transplantation.Opportunities and challenges of proteomics in pediatric patients: circulating biomarkers after hematopoietic stem cell transplantation as a successful example.Serum levels of caspase-cleaved cytokeratin-18 in patients with severe traumatic brain injury are associated with mortality: a pilot study.Are there new approaches for diagnosis, therapy guidance and outcome prediction of sepsis?Regenerating islet-derived 3-alpha is a biomarker of gastrointestinal graft-versus-host disease.Clinical applications for biomarkers of acute and chronic graft-versus-host disease.Plasma biomarkers of lower gastrointestinal and liver acute GVHD.In Vivo Effects of Mesenchymal Stromal Cells in Two Patients With Severe Acute Respiratory Distress Syndrome.Discovery and validation of graft-versus-host disease biomarkersCellular and molecular mechanisms of liver injury.A biomarker panel for acute graft-versus-host diseaseGenomic and proteomic analysis of allogeneic hematopoietic cell transplant outcome. Seeking greater understanding the pathogenesis of GVHD and mortality.Cell death serum biomarkers are early predictors for survival in severe septic patients with hepatic dysfunctionPlasma biomarkers in graft-versus-host disease: a new era?Immune-mediated liver diseases: programmed cell death ligands and circulating apoptotic markers.Potential biomarkers for early detection of acute graft-versus-host disease.Serological Epithelial Component Proteins Identify Intestinal Complications in Crohn's Disease.B Lymphocyte Chemoattractant (CXCL13) Is an Indicator of Acute Gastrointestinal GVHD in Murine Model.The Role of Biomarkers in the Diagnosis and Risk Stratification of Acute Graft-versus-Host Disease: A Systematic Review.Plasma microRNA-586 is a new biomarker for acute graft-versus-host disease.The Clinical Significance of Serum Apoptotic Cytokeratin 18 Neoepitope M30 (CK-18 M30) and Matrix Metalloproteinase 2 (MMP-2) Levels in Chronic Hepatitis B Patients with Cirrhosis.Is alanine aminotransferase level a surrogate biomarker of hepatic apoptosis in nonalcoholic fatty liver disease?Elevated serum levels of cell death circulating biomarkers, M30 and M65, in patients with β-thalassemia major.Pentostatin for treatment of steroid-refractory acute GVHD: a retrospective single-center analysis.The predictive value of selected serum microRNAs for acute GVHD by TaqMan MicroRNA arrays.Biomarkers for post-transplantation outcomes.Immunomonitoring of MSC-Treated GvHD Patients Reveals Only Moderate Potential for Response Prediction but Indicates Treatment Safety.Piceatannol increases the expression of hepatocyte growth factor and IL-10 thereby protecting hepatocytes in thioacetamide-induced liver fibrosis.
P2860
Q24657673-33DAE147-3A0B-4A79-BE17-77A49C7F5B2EQ26768672-2A135F31-CE77-4E76-B9C8-09157EB2B631Q26777674-73090D4A-0559-4366-87D5-9DEA58BAE452Q26824540-CF8F1CFC-038B-409A-8181-1224EB63F7BEQ33746617-989A3E9E-8B5A-4111-A567-881AD1DF1EA0Q33895173-EC93EF3A-454E-422B-B7A5-2E2F0ECB5039Q34301831-596DA579-F404-45C2-804D-0258BE98385EQ34698815-A0371F1D-8026-4716-B155-2F9C19D8DB43Q35022269-C6BFC7D5-5FA2-4318-86F2-D5B95BFCF9B9Q35180727-604F162F-B27B-425D-97F3-4716412A854FQ35231584-C0057E96-151F-40D8-B84A-EEC580B9EC99Q35622257-267A2E41-3C76-4E23-8C93-91B6C199A122Q35623673-8106DAA1-32C6-4B47-B76F-6CE3FCD54F47Q35767289-DCE7DE60-CFFD-487D-B5CF-31E4649312D5Q35891657-6D7D2CBB-AF4C-436D-9CC3-2F5588D25ED1Q36067836-0B92DDE1-903B-4B4E-8C7A-E12494E16B05Q36569667-4C939C81-4A57-4687-A2E7-529CFC910F3AQ36908855-D8E1A27B-31A8-44E2-943F-3EAA366E40E6Q37041904-255A83EC-A97D-4720-A092-747ECB4AC650Q37262519-39ACAC92-9874-4F50-B95B-72B13C46C3CDQ37279896-0848A544-6147-489C-9773-266184349CBAQ37369393-8D6C6916-3649-4A5B-BDC0-0C07C45BFE1BQ37418054-3EFE53EB-3297-4B42-88BD-7891941BD38CQ38038568-587C4564-1A4E-4CC8-A13A-79AFFBFD36F5Q38376993-0E541FA5-5992-4755-9B34-721E5E2B0C43Q38688669-71908A07-2A81-4AF7-B63B-EA8479BAEC76Q38829335-FB7F75F1-B7F9-4E58-9E7E-58208653DEB8Q41178078-024EFAE7-C281-41D2-BED9-5919FAA8FB09Q42247927-720B3B8E-9B71-4C34-A9C9-E0B1923DA932Q43092106-29A12567-BCE7-49F0-B4C5-A9E22A9F7949Q43721625-7EB4C047-B5D2-406F-A2C6-4B27276B46B9Q44005585-F62ECDC2-D86F-4D0F-A35B-6C65B21AF689Q51555000-8AB5AEB1-C362-4C69-9BEE-D49F55585232Q52603913-EF6CC528-7B6D-40A4-9CEF-42648465E841Q52667946-F4AA4FAE-686E-4620-9008-A9FBE9F1E7C6Q53762825-8EC7290D-969D-4DAC-99B8-DC8DB8F692D6
P2860
Serum cytokeratin-18 fragments as quantitative markers of epithelial apoptosis in liver and intestinal graft-versus-host disease.
description
2007 nî lūn-bûn
@nan
2007 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Serum cytokeratin-18 fragments ...... nal graft-versus-host disease.
@ast
Serum cytokeratin-18 fragments ...... nal graft-versus-host disease.
@en
Serum cytokeratin-18 fragments ...... nal graft-versus-host disease.
@nl
type
label
Serum cytokeratin-18 fragments ...... nal graft-versus-host disease.
@ast
Serum cytokeratin-18 fragments ...... nal graft-versus-host disease.
@en
Serum cytokeratin-18 fragments ...... nal graft-versus-host disease.
@nl
prefLabel
Serum cytokeratin-18 fragments ...... nal graft-versus-host disease.
@ast
Serum cytokeratin-18 fragments ...... nal graft-versus-host disease.
@en
Serum cytokeratin-18 fragments ...... nal graft-versus-host disease.
@nl
P2093
P1433
P1476
Serum cytokeratin-18 fragments ...... nal graft-versus-host disease.
@en
P2093
Anthony D Ho
Axel Benner
Martin Görner
Michael Conzelmann
Michael Hess
Michael Rieger
Peter Dreger
Thomas Luft
Ulrich Strohhaecker
Ute Hegenbart
P304
P356
10.1182/BLOOD-2006-10-049817
P407
P577
2007-08-16T00:00:00Z